Effects of methotrexate-carcinoembryonic-antigen-antibody immunoconjugates on GW-39 human tumors in nude mice
- 19 Downloads
Methotrexate (MTX) was conjugated to an anti-carcinoembryonic antigen monoclonal antibody (NP2) by using amino-dextran as an intermediate carrier. The drug was chemically linked to amino-dextran (averageMr = 40000), and the resulting MTX-dextran was then site-specifically attached to the carbohydrate moiety of the antibody. Athymic nude mice that carried human colonic GW-39 tumors (s. c.) were treated with the immunoconjugate. In this study, the specific conjugate caused a greater inhibition of the tumor growth than either free MTX or its conjugate with dextran and an irrelevant antibody. The intermediate MTX-dextran and the unlinked mixture of MTX-dextran with NP2 were both relatively ineffective in inhibiting tumor growth. The greatly reduced host toxicity permitted the use of the MTX-dextran-NP2 in a high-dose therapy of this tumor system.
KeywordsTumor Growth Methotrexate Dextran Nude Mouse Human Tumor
Unable to display preview. Download preview PDF.
- 3.Dillman RO (1987) Antibody therapy. In: Oldham RK (ed) Principles of cancer biotherapy. Raven Press, New York, p 291Google Scholar
- 21.Sharkey RM, Goldenberg DM, Goldenberg H, Lee RE, Ballance C, Pawlyk D, Varga D, Hansen HJ (1990) Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. Cancer Res (in press)Google Scholar
- 23.Sokal RR, Rohlf FJ (1969) Biometry. Freeman, San Francisco, pp 226–235Google Scholar
- 24.Sokal RR, Rohlf FJ (1969) Statistical tables. Freeman, San Francisco, p 159Google Scholar
- 25.Trouet A, Masquelier M, Baurain R, Deprez-De Campeneere (1982) A covalent linkage between daunorubicin and protein that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies. Proc Natl Acad Sci USA 79: 626Google Scholar
- 27.Yang HM, Reisfeld RA (1988) Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice. Proc Natl Acad Sci USA 85: 1189sGoogle Scholar